Profile
LanceBio Ventures is a Cyprus-based biotech investment management company focused on early-stage investments (late preclinical to Phase 3) in North American and European biotech and life sciences companies. It boasts over $200m deployed in early-stage biotech with a focus on therapeutics for diseases with high unmet needs, such as genetic, autoimmune, and oncological conditions.
Industry
Region of investment
Lancebio Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
LanceBio Ventures Fund
|
Venture Capital (VC)
|
Biotechnology
Life Sciences
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$200 M
|
April 2026
|
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about Lancebio Ventures
Where is Lancebio Ventures located?
Lancebio Ventures is located in Λευκωσία, Nicosia, Cyprus.
When was Lancebio Ventures founded?
Lancebio Ventures was founded in .
What sectors and industries does Lancebio Ventures invest in?
Lancebio Ventures invests in companies and startups in Biotechnology, Life Sciences.
What is Lancebio Ventures geographical focus of investments?
Lancebio Ventures invests in companies and startups in North America, Europe.
At what stages of companies and startups does Lancebio Ventures typically invest in?
Lancebio Ventures invests in companies and startups at Pre-seed, Seed.
What is the usual amount of Lancebio Ventures investment?
Lancebio Ventures usually invests $5-10 m on average.
What is the amount of assets of under management (AUM) for Lancebio Ventures?
Lancebio Ventures has around $200m assets under management.
When was Lancebio Ventures last fund created?
Lancebio Ventures last fund was created/launched in 2026-04-29